Effect of 15g Daily Consumption of NUTRIOSE on Healthy Volunteers Microbiota. (ROQ_NUTRIFLORE)

July 9, 2013 updated by: Nealth Sarl

Effect of 15g Daily Consumption of NUTRIOSE During 2 and 4 Weeks on Healthy Volunteers Microbiota and Digestive Tolerance.

NUTRIOSE is a food ingredient defined as a carbohydrate polymer of vegetable origin (wheat starch or corn) with a degree of polymerization ≥ 3 and chemically transformed. It is soluble in aqueous solution, very poorly digested in the small intestine, it mostly reaches the colon where it stimulates fermentation. AFSSA, in its opinion of July 30, 2007, considers that this ingredient is a "soluble dietary fiber." The objective of this research is to determine, among healthy subjects, the effect of this dietary fiber on changes in gut microbiota and digestive tolerance during a 28 days consumption. Microbiological analyzes will be performed by RT-PCR. Digestive tolerance will be measured by the intelligence of a questionnaire by volunteers.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bobigny, France, 93009
        • Hopital Avicenne- Centre de Recherche Sur Volontaires-Service de Gastroenterologie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • aged 20 to 50 years,
  • BMI 18 to 25 kg/m2,
  • absence of known or scalable organic or psychiatric disease
  • no history of chronic gastrointestinal disease
  • having a bowel regularity (1-3 defecation per day, of normal consistency),
  • person without medication during the study (especially laxatives, anti diarrheal) (except contraceptives in women)
  • having normal laboratory hepatic and renal tests (ASAT, ALAT, GGT, urea, creatinine)
  • no pregnant nor nursing women
  • covered by Social Security
  • negative serology for hepatitis B/C and HIV
  • who signed the informed consent form

Exclusion Criteria:

  • persons abusing drugs (laxatives, anti-diarrheal)
  • person who doesn't want to stop taking food supplements containing pre- or probiotics during time of the study
  • person intolerant to gluten and / or allergic to wheat flour
  • person in vegetarian or vegan diet
  • Inclusion in another clinical study
  • subjects receiving over 4,500 Euros in the last 12 months (including the present study)
  • subjects presenting risk of non-compliance in the opinion of the recruiting doctor.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: NUTRIOSE
group of volunteers fed with NUTRIOSE
15g/day NUTRIOSE FB06
Active Comparator: GLUCIDEX
gruop of volunteers fed with GLUCIDEX
15g/day GLUCIDEX 21

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Clostridium Perfringens rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28

Secondary Outcome Measures

Outcome Measure
Time Frame
digestive tolerance
Time Frame: J0 to J28 (every day)
J0 to J28 (every day)
stool pH
Time Frame: D0 ; D14; D28
D0 ; D14; D28
total stool flora
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Bacteroides rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Eubacterium rectal rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Clostridium coccoides rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Clostridium leptum rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Bifidobacteria rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Lactobacteria rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Streptococcus rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Enterococcus rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Bacteroidetes rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Actinobacteria rate in stool
Time Frame: D0 ; D14; D28
D0 ; D14; D28
Firmicutes rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
E. Coli rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Clostridium difficile rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Faecalibacterium prausnitzii rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Clostridium difficile typa A and B rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
E. Coli EIEC + EPEC (eae gene) rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Shigella + E. Coli EIEC (ipaH gene) rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Listeria Monocytogenes rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28
Yersinia Enterocolitica rate in stool
Time Frame: D0 ; D14 ; D28
D0 ; D14 ; D28

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Robert BENAMOUZIG, MD,PhD, Centre de Recherche en Nutrition Humaine d'Ile-de-France

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2012

Primary Completion (Actual)

August 1, 2012

Study Completion (Actual)

August 1, 2012

Study Registration Dates

First Submitted

July 9, 2013

First Submitted That Met QC Criteria

July 9, 2013

First Posted (Estimate)

July 12, 2013

Study Record Updates

Last Update Posted (Estimate)

July 12, 2013

Last Update Submitted That Met QC Criteria

July 9, 2013

Last Verified

July 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • ROQ_NUTRIFLORE10

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Microbiota

Clinical Trials on NUTRIOSE FB06

3
Subscribe